Lehmann He

531 citations
76 papers · 363 · h-index 10

Impact in

    • Schizophrenia research and treatment
    • Electroconvulsive Therapy Studies
    • Attention Deficit Hyperactivity Disorder
    • Bipolar Disorder and Treatment
    • Epilepsy research and treatment
  • Pharmacology top 10%
    • Treatment of Major Depression

Papers in

Lehmann He

65 papers receiving 278 citations

Peers

Lehmann He
Comparison fields: 5 of 77
  • Psychiatry and Mental health 156
  • Pharmacology 90
  • Cellular and Molecular Neuroscience 68
  • Biological Psychiatry 8
  • General Psychology 4
Replace Abraham Flemenbaum with:
Abraham Flemenbaum United States
Gallant Dm United States
P. Danjou France
Cosmo Hallström United Kingdom
JOSEPH A. BARSA United States
N. Schooler United States
Jack Shelton United States
AW Peck United Kingdom
Isham Kimbell United States
K Kadlec Canada
Lehmann He relative to Abraham Flemenbaum United States Abraham Flemenbaum's profile →
Citations per field
00.5×
Abraham Flemenbaum · 1×
Citations per year

Countries citing papers authored by Lehmann He

Since Specialization
Citations

This map shows the geographic impact of Lehmann He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lehmann He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lehmann He more than expected).

Fields of papers citing papers by Lehmann He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lehmann He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lehmann He. The network helps show where Lehmann He may publish in the future.

Co-authors

The 16 scholars most cited alongside Lehmann He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lehmann He Line = papers co-authored together Lehmann He links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Therapeutic results with chlorpromazine (largactil) in psychiatric conditions.
195520
2
Pimozide in the treatment of chronic schizophrenic patients.
197020
3
A double-blind, comparative clinical trial with ludiomil (CIBA 34,276-Ba) and amitriptyline in newly admitted depressed patients.
197315
4
Comparative pharmacotherapy of the aging psychotic patient.
196715
5
A comparison of desipramine and amitriptyline plasma levels and therapeutic response.
197815
6
A comparative evaluation of doxepin and chlordiazepoxide in the treatment of psychoneurotic outpatients.
197014
7
Chemical reduction of the compulsion to drink with metronidazole: a new treatment modality in the therapeutic program of the alcoholic.
196713
8
Psychometric tests in evaluation of brain pathology, response to drugs.
197013
9
Negative findings with megavitamins in schizophrenic patients: preliminary report.
197713
10
Fluspirilene in the treatment of chronic schizophrenic patients.
197011
11
[An inhibiting drug for control and treatment of psychomotoric states of excitability (chlorpromazine, largactil, thorazine, megaphen)].
19549
12
A preliminary investigation of WY-3263 versus amitriptyline in depressions.
19689
13
Clinical observations with beta-endorphin injections.
19788
14
Treatment of depression with dexedrine and demerol.
19718
15
Thiothixene and the thioxanthenes.
19748
16
Comprehensive clinical studies with trazodone.
19737
17
The effect of hypnotics on rapid eye movement (REM).
19687
18
Systematic clinical studies with trazodone: methodological aspects.
19737
19
The emotional basis of illness.
19676
20
Pharmacotherapy of schizophrenia.
19666

About Lehmann He

Lehmann He is a scholar working on Psychiatry and Mental health, Clinical Psychology, Pharmacology, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 76 papers that have together received 363 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (11 papers), Treatment of Major Depression (6 papers), Electroconvulsive Therapy Studies (5 papers), Pain Management and Placebo Effect (5 papers), Attention Deficit Hyperactivity Disorder (4 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers), Epilepsy research and treatment (3 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). The work is most often cited by research in Psychiatry and Mental health (156 citations), Pharmacology (90 citations), Cellular and Molecular Neuroscience (68 citations), Biological Psychiatry (8 citations) and General Psychology (4 citations). Lehmann He has collaborated with scholars based in Canada. Frequent co-authors include Ban Ta, G Chouinard, R Cooper, Marcus-André Deutsch, Mohamed Amin, Milan R. Amin, Pascal Roy, Stewart Ja, Muhammad Amin and Joanne Bennett. Their work appears in journals such as PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact